📰 Cingulate News
Page 3 - Cingulate News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Cingulate. Real-time updates on events, politics, business and more.
March 30, 2023
Cingulate Inc. (NASDAQ:CING – Get Rating) was the recipient of a large drop in short interest in March. As of March 15th, there was short interest totalling 404,000 shares, a drop of 62.2% from the February 28th total of 1,070,000 shares. Based on an average daily volume of 848,400 shares, the days-to-cover ratio is currently […]
March 13, 2023
Go-to-Market Solution Provides Full Commercial Support for the First, True Entire Active-Day Medication Designed to treat ADHD Indegene Model Geared for Efficient National Commercial Launch in Multibillion-Dollar
June 14, 2022
Security correspondent. hearing the kind of reaction that activists are having, what about reaction from saudi arabia? saudi arabia is quite _ reaction from saudi arabia? saudi arabia is quite a _ reaction from saudi arabia? saudi arabia is quite a substantial- arabia is quite a substantial community in their cingulate very much forward to this visit and that the us president is notjust going to be meeting the king was that of state and his sun, the crown prince, but it is also going to attend a...
June 2, 2022
KANSAS CITY, Kan., June 02, 2022 (GLOBE NEWSWIRE) -- Cingulate Inc. (NASDAQ: CING), a clinical-stage biopharmaceutical company utilizing its proprietary...
March 12, 2022
Cingulate (NASDAQ:CING – Get Rating) released its quarterly earnings data on Thursday. The company reported ($0.32) EPS for the quarter, topping analysts’ consensus estimates of ($0.39) by $0.07, MarketWatch Earnings reports. Shares of CING remained flat at $$1.19 during midday trading on Friday. 17,376 shares of the stock traded hands, compared to its average volume […]
December 10, 2021
NEW YORK, NY / ACCESSWIRE / December 10, 2021 / Aegis Capital Corp. acted as Lead Bookrunning Manager on a $25 Million Initial Public Offering of Common Stock for Cingulate Inc. (NASDAQ:CING).Cingulate
December 10, 2021
10.12.2021 - NEW YORK, NY / ACCESSWIRE / December 10, 2021 / Aegis Capital Corp. acted as Lead Bookrunning Manager on a $25 Million Initial Public Offering of Common Stock for Cingulate Inc. (NASDAQ:CING).Cingulate Inc.Cingulate Inc. is a clinical-stage ...